These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6440937)

  • 21. [Spinocerebellar degeneration].
    Takayanagi T
    Nihon Naika Gakkai Zasshi; 1993 Mar; 82(3):377-80. PubMed ID: 8315331
    [No Abstract]   [Full Text] [Related]  

  • 22. Spinocerebellar degeneration and neuropeptides.
    Matsuoka Y; Sakurai N
    Jpn J Med; 1989; 28(6):791-3. PubMed ID: 2517445
    [No Abstract]   [Full Text] [Related]  

  • 23. [Spinocerebellar degeneration and neuropeptides].
    Matsuoka Y; Sakurai N
    Nihon Naika Gakkai Zasshi; 1989 Dec; 78(12):1705-8. PubMed ID: 2516527
    [No Abstract]   [Full Text] [Related]  

  • 24. Amyotrophic lateral sclerosis: a double-blind crossover trial of thyrotropin-releasing hormone.
    Imoto K; Saida K; Iwamura K; Saida T; Nishitani H
    J Neurol Neurosurg Psychiatry; 1984 Dec; 47(12):1332-4. PubMed ID: 6439824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analysis of the abnormal ocular movements in spinocerebellar degenerations and the influence of the thyrotropin releasing hormone (author's transl)].
    Yamamoto H; Sobue I
    Rinsho Shinkeigaku; 1980 Aug; 20(8):637-45. PubMed ID: 6777105
    [No Abstract]   [Full Text] [Related]  

  • 26. Controlled trial of thyrotropin releasing hormone in amyotrophic lateral sclerosis.
    Brooke MH; Florence JM; Heller SL; Kaiser KK; Phillips D; Gruber A; Babcock D; Miller JP
    Neurology; 1986 Feb; 36(2):146-51. PubMed ID: 3080694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current status of thyrotropin-releasing hormone therapy in amyotrophic lateral sclerosis. Committee on Health Care Issues, American Neurological Association.
    Ann Neurol; 1987 Oct; 22(4):541-3. PubMed ID: 3124710
    [No Abstract]   [Full Text] [Related]  

  • 28. [Noradrenaline metabolism in the brain of rolling mouse Nagoya and the influence of thyrotropin releasing hormone (author's transl)].
    Konagaya M; Takayanagi T; Muroga T; Adachi K; Sobue I
    Rinsho Shinkeigaku; 1980 Mar; 20(3):181-8. PubMed ID: 6103773
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical manifestations and thyrotropin releasing hormone therapy in cerebellar degenerations.
    Wang HC; Chiu HC
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Mar; 47(3):161-8. PubMed ID: 1848143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protirelin (TRH) in depression.
    Hollister LE; Berger P; Ogle FL; Arnold RC; Johnson A
    Arch Gen Psychiatry; 1974 Oct; 31(4):468-70. PubMed ID: 4214026
    [No Abstract]   [Full Text] [Related]  

  • 31. A double-blind crossover sequential trial of oral thyrotrophin-releasing hormone in depression.
    Mountjoy CQ; Price JS; Weller M; Hunter P; Hall R; Dewar JH
    Lancet; 1974 May; 1(7864):958-60. PubMed ID: 4133645
    [No Abstract]   [Full Text] [Related]  

  • 32. Thyrotrophin-releasing hormone in the treatment of depression.
    Coppen A; Montgomery S; Peet M; Bailey J; Marks V; Woods P
    Lancet; 1974 Aug; 2(7878):433-4. PubMed ID: 4137322
    [No Abstract]   [Full Text] [Related]  

  • 33. A double-blind trial of intravenous thyrotrophin-releasing hormone in the treatment of reactive depression.
    Evans LE; Hunter P; Hall R; Johnston M; Roy VM
    Br J Psychiatry; 1975 Sep; 127():227-30. PubMed ID: 810198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement in mental depression with decreased thyrotropin response after administration of thyrotropin-releasing hormone.
    Kastin AJ; Ehrensing RH; Schalch DS; Anderson MS
    Lancet; 1972 Oct; 2(7780):740-2. PubMed ID: 4116150
    [No Abstract]   [Full Text] [Related]  

  • 35. [Amine metabolites in cerebrospinal fluids and thyrotropin releasing hormone in spinocerebellar degeneration].
    Arai M
    Rinsho Shinkeigaku; 1988 Jun; 28(6):595-604. PubMed ID: 2466598
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of the effect of thyrotropin releasing hormone (TRH) on regional cerebral blood flow in spinocerebellar degeneration using 3DSRT.
    Kimura N; Kumamoto T; Masuda T; Nomura Y; Hanaoka T; Hazama Y; Okazaki T; Arakawa R
    J Neurol Sci; 2009 Jun; 281(1-2):93-8. PubMed ID: 19286195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The influence of thyrotropin releasing hormone on the abnormal ocular movements of the brainstem involvement].
    Yamamoto H; Mizuno Y; Takayanagi T; Iida M; Sobue I
    Rinsho Shinkeigaku; 1985 Apr; 25(4):385-92. PubMed ID: 3926369
    [No Abstract]   [Full Text] [Related]  

  • 38. Changes in brain catecholamines and spontaneous locomotor activity in response to thyrotropin releasing hormone.
    Agarwal RA; Rastogi RB; Singhal RL
    Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):743-52. PubMed ID: 12549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thyrotropin-releasing hormone in acute pancreatitis. A preliminary report.
    Kiviniemi H; Laitinen S; Ståhlberg M; Larmi M; Kairaluoma M
    Acta Chir Scand; 1986 Jan; 152():43-7. PubMed ID: 2420106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thyrotropin-releasing hormone (TRH) and Alzheimer's disease.
    Peabody CA; Deblois TE; Tinklenberg JR
    Am J Psychiatry; 1986 Feb; 143(2):262-3. PubMed ID: 3080909
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.